Frank Karbe
2018
In 2018, Frank Karbe earned a total compensation of $2.2M as Principal Financial and Accounting Officer at Myovant Sciences Ltd., a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,000 |
|---|---|
| Option Awards | $1,665,485 |
| Salary | $410,000 |
| Other | $332 |
| Total | $2,239,817 |
Karbe received $1.7M in option awards, accounting for 74% of the total pay in 2018.
Karbe also received $164K in non-equity incentive plan, $410K in salary and $332 in other compensation.
Rankings
In 2018, Frank Karbe's compensation ranked 5,144th out of 14,244 executives tracked by ExecPay. In other words, Karbe earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,144 out of 14,244 | 64th |
Division Manufacturing | 1,940 out of 5,765 | 66th |
Major group Chemicals And Allied Products | 710 out of 2,128 | 67th |
Industry group Drugs | 594 out of 1,817 | 67th |
Industry Pharmaceutical Preparations | 457 out of 1,391 | 67th |
Source: SEC filing on July 25, 2019.
Karbe's colleagues
We found four more compensation records of executives who worked with Frank Karbe at Myovant Sciences Ltd. in 2018.
News
Myovant Sciences Ltd. Principal Executive Officer David Marek's 2021 pay jumps 154% to $6.2M
July 27, 2022
Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2019 pay jumps 40% to $6.2M
July 24, 2020
Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2018 pay falls 64% to $4.4M
July 25, 2019